Universal Beteiligungs und Servicegesellschaft mbH Buys 3,799 Shares of Humana Inc. (NYSE:HUM)

Universal Beteiligungs und Servicegesellschaft mbH raised its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 6.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 64,488 shares of the insurance provider's stock after purchasing an additional 3,799 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH owned 0.05% of Humana worth $17,064,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also added to or reduced their stakes in the company. Guidance Capital Inc. bought a new position in Humana in the first quarter valued at $245,000. HighPoint Advisor Group LLC increased its stake in Humana by 15.2% in the first quarter. HighPoint Advisor Group LLC now owns 1,739 shares of the insurance provider's stock valued at $451,000 after acquiring an additional 230 shares during the last quarter. Gries Financial LLC bought a new position in Humana in the first quarter valued at $221,000. Lindbrook Capital LLC increased its stake in Humana by 61.1% in the first quarter. Lindbrook Capital LLC now owns 1,020 shares of the insurance provider's stock valued at $270,000 after acquiring an additional 387 shares during the last quarter. Finally, Teachers Retirement System of The State of Kentucky increased its stake in Humana by 4.0% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 9,293 shares of the insurance provider's stock valued at $2,459,000 after acquiring an additional 361 shares during the last quarter. Institutional investors own 92.38% of the company's stock.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Guggenheim assumed coverage on Humana in a research note on Wednesday, April 9th. They issued a "buy" rating and a $326.00 target price on the stock. Truist Financial cut their price target on shares of Humana from $280.00 to $260.00 and set a "hold" rating for the company in a research report on Wednesday, July 16th. Robert W. Baird cut their price target on shares of Humana from $300.00 to $297.00 and set a "neutral" rating for the company in a research report on Friday. Barclays set a $268.00 price target on shares of Humana and gave the company an "equal weight" rating in a research report on Thursday, June 12th. Finally, Wall Street Zen upgraded shares of Humana from a "hold" rating to a "buy" rating in a research report on Sunday, July 20th. Sixteen research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $282.43.

Humana Stock Down 1.1%

Shares of HUM traded down $2.62 on Monday, hitting $235.36. 355,484 shares of the stock traded hands, compared to its average volume of 1,695,072. The company has a market capitalization of $28.41 billion, a PE ratio of 16.64, a P/E/G ratio of 1.63 and a beta of 0.44. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.91 and a current ratio of 1.91. The business has a 50 day simple moving average of $234.56 and a 200 day simple moving average of $256.11. Humana Inc. has a one year low of $206.87 and a one year high of $406.09.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, beating the consensus estimate of $10.07 by $1.51. The company had revenue of $32.11 billion during the quarter, compared to the consensus estimate of $32 billion. Humana had a net margin of 1.42% and a return on equity of 14.47%. The firm's quarterly revenue was up 8.4% compared to the same quarter last year. During the same quarter last year, the firm earned $7.23 earnings per share. As a group, equities analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.